LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Perrigo Co PLC

Cerrado

SectorSalud

10.72 -4.2

Resumen

Variación precio

24h

Actual

Mínimo

10.63

Máximo

11.2

Métricas clave

By Trading Economics

Ingresos

-1.4B

-1.4B

Ventas

66M

1.1B

BPA

0.77

Rentabilidad por dividendo

8.97

Margen de beneficio

-127.478

Empleados

8,100

EBITDA

-21M

140M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+279.46% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

8.97%

2.25%

Próximas Ganancias

6 may 2026

Fecha Próximo Dividendo

24 mar 2026

Próxima Fecha de Ex Dividendo

29 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-304M

1.7B

Apertura anterior

14.92

Cierre anterior

10.72

Noticias sobre sentimiento de mercado

By Acuity

15%

85%

23 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Perrigo Co PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 jul 2025, 13:01 UTC

Adquisiciones, fusiones, absorciones

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14 jul 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 jul 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 jul 2025, 12:32 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 jul 2025, 12:31 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 jul 2025, 12:31 UTC

Adquisiciones, fusiones, absorciones

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 jul 2025, 12:30 UTC

Adquisiciones, fusiones, absorciones

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparación entre iguales

Cambio de precio

Perrigo Co PLC Esperado

Precio Objetivo

By TipRanks

279.46% repunte

Estimación a 12 meses

Media 42.5 USD  279.46%

Máximo 68 USD

Mínimo 17 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Perrigo Co PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

25.22 / 26.85Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

23 / 351 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
help-icon Live chat